Summary
- Current Price
- As of today, MNPR price is $97.79, up +2.90% on
- Current Price All-Time High
- MNPR price is currently -59.25% below its historical high of $240.00 set on
- Market Cap
- MNPR current market cap is $655M, up +204.07% over the past 365 days
- PE Ratio
- MNPR PE ratio is unknown
- Revenue
- MNPR current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for MNPR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Monopar Therapeutics Inc. |
| Ticker | NASDAQ: MNPR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | monopartx.com |
| Employees | 14 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $97.79 | |
| Price, 1D Change | +2.90% | |
| $655M | ||
| - | ||
| - | ||
| 1.57 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.85 | ||
| EPS, 1Y Change | +54.99% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.85 | ||
| EPS Estimate | N/A | -$2.90 |
| EPS Est. Change | N/A | -56.89% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $97.79 | |
| Price Target | - | $115.00 |
| Price Tgt. Change | - | +17.60% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.77 | -$4.11 | -131.90% | |
| -$1.67 | -$1.85 | -10.67% | |
| -$2.90 | N/A | -56.89% | |
| -$3.14 | N/A | -69.52% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $15.85M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $97.79 | |
| $68.57 | ||
| $64.96 | ||
| $61.37 | ||
| $69.01 | ||
| $9.26 | ||
| 1.57 | ||
| $5.75 | ||
| 83.18 | ||
| 99.81% | ||
| 81.11% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.85 | ||
| $0.00 | ||
| - | ||
| -$16.70M | ||
| - | ||
| -$13.72M | ||
| - | ||
| -$16.70M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 51.35 | ||
| 51.35 | ||
| - | ||
| - | ||
| 136.28 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 4.84 | ||
| -27.68 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $137.83M | ||
| $140.40M | ||
| $140.72M | ||
| $140.46M | ||
| $2.89M | ||
| $2.74M | ||
| $154.90K | ||
| $0.00 | ||
| $2.74M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $13.72M | ||
| $16.70M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$12.20M | ||
| -$63.45M | ||
| $91.57M | ||
| $0.00 | ||
| -$12.20M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| BTIG | → | |
| BTIG | → | |
| Chardan Capital | → | |
| BTIG | → | |
| Morgan Stanley | ||
| Raymond James | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with MNPR
FAQ
What is the ticker symbol for Monopar Therapeutics Inc.?
The ticker symbol for Monopar Therapeutics Inc. is NASDAQ:MNPR
Does Monopar Therapeutics Inc. pay dividends?
No, Monopar Therapeutics Inc. does not pay dividends
What sector is Monopar Therapeutics Inc. in?
Monopar Therapeutics Inc. is in the Healthcare sector
What industry is Monopar Therapeutics Inc. in?
Monopar Therapeutics Inc. is in the Biotechnology industry
What country is Monopar Therapeutics Inc. based in?
Monopar Therapeutics Inc. is headquartered in United States
When did Monopar Therapeutics Inc. go public?
Monopar Therapeutics Inc. initial public offering (IPO) was on December 19, 2019
Is Monopar Therapeutics Inc. in the S&P 500?
No, Monopar Therapeutics Inc. is not included in the S&P 500 index
Is Monopar Therapeutics Inc. in the NASDAQ 100?
No, Monopar Therapeutics Inc. is not included in the NASDAQ 100 index
Is Monopar Therapeutics Inc. in the Dow Jones?
No, Monopar Therapeutics Inc. is not included in the Dow Jones index
When was Monopar Therapeutics Inc. last earnings report?
Monopar Therapeutics Inc.'s most recent earnings report was on May 14, 2026
When does Monopar Therapeutics Inc. report earnings?
The next expected earnings date for Monopar Therapeutics Inc. is August 13, 2026
Data Sources & References
- MNPR Official Website www.monopartx.com
- MNPR Profile on Yahoo Finance finance.yahoo.com/quote/MNPR
- MNPR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mnpr